Pharmaceutical scholarship

A NEW Macquarie University Pharmaceutical Scholarship Endowment (MUAP), the first of its kind in Australia, has been awarded to Kyu Park, a researcher who has completed his actuarial studies.

His scholarship was presented to him by the Federal Member for Bennelong, John Alexander MP, at Friday’s launch of the Scholarship Program.

The MUAP, which is jointly funded by industry and the University, offers those top graduates looking to undertake research with a full scholarship.

Macquarie University partnered with five Australian pharmaceutical companies, AMGEN Australia, Roche, MSD, Janssen and Pfizer to develop the MUAP, which delivers a unique and innovative Higher Degree Research (HDR) Scholarship program in research areas relevant to pharmaceutical policy, medicines management and the use of medicines data to better inform policy decisions.

John Alexander and Kyu were joined by representatives of the five Australian pharmaceutical industry MUAP partners, researchers from the Macquarie University Centre for the Health Economy (MUCHE) and the Deputy Vice Chancellor for Research at the University’s Art Gallery within the Chancellery.

Alexander said the Scholarship Program would make an important contribution to future Australian health policy.

Pictured from left are Professor Sakkie Pretorius, Macquarie University; Louise Graham, Pfizer; Sean Lybrand, AMGEN; John Alexander MP; Kyu Park; Dr Henry Cutler, Centre for Health Economy; Melissa McGregor, Pfizer; Martin Snoake, Roche; Michael Azmuk, MSD; and Stuart Englund, Janssen.